Multiplatform Molecular Testing as an Adjunct to Fine Needle Aspiration in the Evaluation of Pediatric Thyroid Nodules
The Journal of Clinical Endocrinology & Metabolism · 16.10.2025 · 110 (11) · e3738-e3744
DOI: 10.1210/clinem/dgaf110 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 04.03.2025. Verfasst von Apoorva Aekka und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL 6…. Hauptthemen laut MEDLINE: Thyroid Nodule, Molecular Diagnostic Techniques, Thyroid Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 49 Literaturangaben.
Abstract (Originalsprache)
Context
Molecular analysis of thyroid cytopathology derived from fine needle aspiration (FNA) improves diagnostic yield and informs presurgical treatment stratification of adults with thyroid nodules. Its use is limited in pediatrics, but it has the potential to guide clinical management for these patients.
Objective
To report on the results of oncogene sequencing and microRNA (miRNA)-based risk classification of thyroid FNA cytopathology in a pediatric cohort.
Design
Retrospective analysis of archived FNA samples collected from patients seen at Lurie Children's Hospital between October 2020 and March 2023; 39 cases were included in the study.
Setting
Referral center. Patients Thirty-seven patients ages 7 to 20 years (mean age 13.9 years).
Interventions
Interpace Diagnostics®’ multiplatform testing including ThyGeNEXT® (oncogene panel) and ThyraMIR® (miRNA risk classifier) was performed on FNA samples. Molecular results were compared to final surgical pathology or repeat FNA results. Main Outcome Measures Description of cohort molecular characteristics; test sensitivity and specificity.
Results
The most common oncogenic alterations among malignant cases were the BRAFV600E variant (38%), RET-PTC1 fusions (14%), and NRAS variants (14%). Nineteen of 21 malignant samples had positive (high-risk) miRNA expression profiles. Fifteen of 18 benign cases had negative (low-risk) miRNA profiles. Multiplatform molecular testing demonstrated 90.5% sensitivity and 88.9% specificity in detecting malignant pathology.
Conclusion
This is the first study to report on the use of combined oncogene and miRNA analysis of FNA cytopathology in a pediatric cohort. Multiplatform molecular testing is a potentially useful adjunct to FNA as a presurgical diagnostic tool in the evaluation of pediatric thyroid nodules.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Endocrinology, Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
- Department of Pathology and Laboratory Medicine, Nationwide Children's Hospital, Ohio State University College of Medicine, Columbus, OH 43205, USA.
- Department of Pathology and Laboratory Medicine, Vancouver General Hospital, University of British Columbia, Vancouver, BC, Canada V5Z 1N1.
- Division of Pediatric Surgery, Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
- Division of Otorhinolaryngology-Head and Neck Surgery, Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
- Department of Assay Development, Interpace Diagnostics, Pittsburgh, PA 15222, USA.
ORCID-Profile: Apoorva Aekka, Nicoleta C Arva, Mehul Raval, Jeffrey Rastatter, Sydney Finkelstein, Venkata Arun Timmaraju, Jami L Josefson
Zitieren
APA
Aekka, A., Arva, N. C., Ren, H. Z., Raval, M., Rastatter, J., Finkelstein, S., Timmaraju, V. A., & Josefson, J. L. (2025). Multiplatform Molecular Testing as an Adjunct to Fine Needle Aspiration in the Evaluation of Pediatric Thyroid Nodules. The Journal of Clinical Endocrinology & Metabolism, 110(11), e3738-e3744. https://doi.org/10.1210/clinem/dgaf110
Vancouver
Aekka A, Arva NC, Ren HZ, Raval M, Rastatter J, Finkelstein S, et al. Multiplatform Molecular Testing as an Adjunct to Fine Needle Aspiration in the Evaluation of Pediatric Thyroid Nodules. The Journal of Clinical Endocrinology & Metabolism. 2025;110(11):e3738-e3744. doi:10.1210/clinem/dgaf110
BibTeX
@article{Aekka2025,
author = {Aekka, Apoorva and Arva, Nicoleta C and Ren, He Zhen and Raval, Mehul and Rastatter, Jeffrey and Finkelstein, Sydney and Timmaraju, Venkata Arun and Josefson, Jami L},
title = {Multiplatform Molecular Testing as an Adjunct to Fine Needle Aspiration in the Evaluation of Pediatric Thyroid Nodules},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2025},
volume = {110},
number = {11},
pages = {e3738--e3744},
doi = {10.1210/clinem/dgaf110}
}
EUVIMED